APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Peptide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Synthetic Peptide Vaccine Market Analysis and Forecast 2026-2032

30 December 2025205 pages

Choose your research edition.

Industry ResearchSynthetic Peptide Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Peptide Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Synthetic Peptide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Peptide Vaccine Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Peptide Vaccine Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Synthetic Peptide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Synthetic Peptide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Synthetic Peptide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Synthetic Peptide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Synthetic Peptide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Synthetic Peptide Vaccine include Merck, Targovax, TapImmune, Sumitomo Dainippon Pharma, Spotlight Innovation, Pharmasyntez, Peptech, OncoTherapy Science and Lytix Biopharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Synthetic Peptide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Synthetic Peptide Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Synthetic Peptide Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Synthetic Peptide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Synthetic Peptide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Synthetic Peptide Vaccine sales, projected growth trends, production technology, application and end-user industry.

Synthetic Peptide Vaccine Segment by Company

Merck

Targovax

TapImmune

Sumitomo Dainippon Pharma

Spotlight Innovation

Pharmasyntez

Peptech

OncoTherapy Science

Lytix Biopharma

ISA Pharmaceuticals

ImmunoCellular Therapeutics

Immatics biotechnologies

Celgene Corporation

Benovus Bio

Artificial Cell Technologies

Apitope Technology

Antigen Express

Anergis

Synthetic Peptide Vaccine Segment by Type

Solution Phase Synthesis (SPS)

Solid Phase Peptide Synthesis (SPPS)

Synthetic Peptide Vaccine Segment by Application

Lung Cancer

Prostate Cancer

Breast Cancer

Gastric Cancer

Pancreatic Cancer

Others

Synthetic Peptide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Peptide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Peptide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Peptide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Synthetic Peptide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Synthetic Peptide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Peptide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solution Phase Synthesis (SPS) Major Manufacturers Table 3. Solid Phase Peptide Synthesis (SPPS) Major Manufacturers Table 4. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Lung Cancer Major Manufacturers Table 6. Prostate Cancer Major Manufacturers Table 7. Breast Cancer Major Manufacturers Table 8. Gastric Cancer Major Manufacturers Table 9. Pancreatic Cancer Major Manufacturers Table 10. Others Major Manufacturers Table 11. Synthetic Peptide Vaccine Industry Trends Table 12. Synthetic Peptide Vaccine Industry Drivers Table 13. Synthetic Peptide Vaccine Industry Opportunities and Challenges Table 14. Synthetic Peptide Vaccine Industry Restraints Table 15. Global Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Synthetic Peptide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Synthetic Peptide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2021-2026) Table 19. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2027-2032) Table 20. Global Synthetic Peptide Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Synthetic Peptide Vaccine Sales by Region (2021-2026) & (K Units) Table 22. Global Synthetic Peptide Vaccine Sales by Region (2027-2032) & (K Units) Table 23. Global Synthetic Peptide Vaccine Sales Market Share by Region (2021-2026) Table 24. Global Synthetic Peptide Vaccine Sales Market Share by Region (2027-2032) Table 25. Global Synthetic Peptide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Synthetic Peptide Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 29. Global Synthetic Peptide Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Synthetic Peptide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Synthetic Peptide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Synthetic Peptide Vaccine Manufacturers, Product Type & Application Table 33. Global Synthetic Peptide Vaccine Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Synthetic Peptide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Synthetic Peptide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021-2026) Table 40. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2027-2032) Table 41. Global Synthetic Peptide Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 43. Global Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 44. Global Synthetic Peptide Vaccine Sales Market Share by Type (2021-2026) Table 45. Global Synthetic Peptide Vaccine Sales Market Share by Type (2027-2032) Table 46. Global Synthetic Peptide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 47. Global Synthetic Peptide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 48. Global Synthetic Peptide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021-2026) Table 52. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2027-2032) Table 53. Global Synthetic Peptide Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 55. Global Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 56. Global Synthetic Peptide Vaccine Sales Market Share by Application (2021-2026) Table 57. Global Synthetic Peptide Vaccine Sales Market Share by Application (2027-2032) Table 58. Global Synthetic Peptide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 59. Global Synthetic Peptide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 60. Merck Company Information Table 61. Merck Business Overview Table 62. Merck Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Merck Synthetic Peptide Vaccine Product Portfolio Table 64. Merck Recent Development Table 65. Targovax Company Information Table 66. Targovax Business Overview Table 67. Targovax Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Targovax Synthetic Peptide Vaccine Product Portfolio Table 69. Targovax Recent Development Table 70. TapImmune Company Information Table 71. TapImmune Business Overview Table 72. TapImmune Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. TapImmune Synthetic Peptide Vaccine Product Portfolio Table 74. TapImmune Recent Development Table 75. Sumitomo Dainippon Pharma Company Information Table 76. Sumitomo Dainippon Pharma Business Overview Table 77. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio Table 79. Sumitomo Dainippon Pharma Recent Development Table 80. Spotlight Innovation Company Information Table 81. Spotlight Innovation Business Overview Table 82. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio Table 84. Spotlight Innovation Recent Development Table 85. Pharmasyntez Company Information Table 86. Pharmasyntez Business Overview Table 87. Pharmasyntez Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pharmasyntez Synthetic Peptide Vaccine Product Portfolio Table 89. Pharmasyntez Recent Development Table 90. Peptech Company Information Table 91. Peptech Business Overview Table 92. Peptech Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Peptech Synthetic Peptide Vaccine Product Portfolio Table 94. Peptech Recent Development Table 95. OncoTherapy Science Company Information Table 96. OncoTherapy Science Business Overview Table 97. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio Table 99. OncoTherapy Science Recent Development Table 100. Lytix Biopharma Company Information Table 101. Lytix Biopharma Business Overview Table 102. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio Table 104. Lytix Biopharma Recent Development Table 105. ISA Pharmaceuticals Company Information Table 106. ISA Pharmaceuticals Business Overview Table 107. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio Table 109. ISA Pharmaceuticals Recent Development Table 110. ImmunoCellular Therapeutics Company Information Table 111. ImmunoCellular Therapeutics Business Overview Table 112. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio Table 114. ImmunoCellular Therapeutics Recent Development Table 115. Immatics biotechnologies Company Information Table 116. Immatics biotechnologies Business Overview Table 117. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio Table 119. Immatics biotechnologies Recent Development Table 120. Celgene Corporation Company Information Table 121. Celgene Corporation Business Overview Table 122. Celgene Corporation Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Celgene Corporation Synthetic Peptide Vaccine Product Portfolio Table 124. Celgene Corporation Recent Development Table 125. Benovus Bio Company Information Table 126. Benovus Bio Business Overview Table 127. Benovus Bio Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Benovus Bio Synthetic Peptide Vaccine Product Portfolio Table 129. Benovus Bio Recent Development Table 130. Artificial Cell Technologies Company Information Table 131. Artificial Cell Technologies Business Overview Table 132. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio Table 134. Artificial Cell Technologies Recent Development Table 135. Apitope Technology Company Information Table 136. Apitope Technology Business Overview Table 137. Apitope Technology Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Apitope Technology Synthetic Peptide Vaccine Product Portfolio Table 139. Apitope Technology Recent Development Table 140. Antigen Express Company Information Table 141. Antigen Express Business Overview Table 142. Antigen Express Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Antigen Express Synthetic Peptide Vaccine Product Portfolio Table 144. Antigen Express Recent Development Table 145. Anergis Company Information Table 146. Anergis Business Overview Table 147. Anergis Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Anergis Synthetic Peptide Vaccine Product Portfolio Table 149. Anergis Recent Development Table 150. North America Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 151. North America Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 152. North America Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 153. North America Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 154. North America Synthetic Peptide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 155. North America Synthetic Peptide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 156. North America Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 159. North America Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 160. North America Synthetic Peptide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 161. North America Synthetic Peptide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 162. North America Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. North America Synthetic Peptide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. North America Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. North America Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 167. North America Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 168. North America Synthetic Peptide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 169. North America Synthetic Peptide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 170. United States Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 171. Canada Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 172. Europe Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 175. Europe Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 176. Europe Synthetic Peptide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Europe Synthetic Peptide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Europe Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 181. Europe Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 182. Europe Synthetic Peptide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Europe Synthetic Peptide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Europe Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Synthetic Peptide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Europe Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 189. Europe Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 190. Europe Synthetic Peptide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Europe Synthetic Peptide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Germany Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 193. France Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 194. U.K. Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Italy Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 197. China Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 198. China Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 199. China Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 200. China Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 201. China Synthetic Peptide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 202. China Synthetic Peptide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 203. China Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 204. China Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 205. China Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 206. China Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 207. China Synthetic Peptide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 208. China Synthetic Peptide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 209. Asia Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 210. Asia Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 211. Asia Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 212. Asia Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 213. Asia Synthetic Peptide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 214. Asia Synthetic Peptide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 215. Asia Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 216. Asia Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 217. Asia Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 218. Asia Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 219. Asia Synthetic Peptide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 220. Asia Synthetic Peptide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 221. Asia Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. Asia Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. Asia Synthetic Peptide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. Asia Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 225. Asia Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 226. Asia Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 227. Asia Synthetic Peptide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 228. Asia Synthetic Peptide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Japan Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 230. South Korea Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 231. India Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Australia Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 233. China Taiwan Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Southeast Asia Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 235. SAMEA Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 236. SAMEA Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 237. SAMEA Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 238. SAMEA Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 239. SAMEA Synthetic Peptide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 240. SAMEA Synthetic Peptide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 241. SAMEA Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 242. SAMEA Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 243. SAMEA Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 244. SAMEA Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 245. SAMEA Synthetic Peptide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 246. SAMEA Synthetic Peptide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 247. SAMEA Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. SAMEA Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 249. SAMEA Synthetic Peptide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 250. SAMEA Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 251. SAMEA Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 252. SAMEA Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 253. SAMEA Synthetic Peptide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 254. SAMEA Synthetic Peptide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 255. Brazil Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 256. Argentina Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 257. Chile Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 258. Colombia Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 259. Peru Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 260. Saudi Arabia Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 261. Israel Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 262. UAE Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 263. Turkey Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 264. Iran Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 265. Egypt Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Table 266. Key Raw Materials Table 267. Raw Materials Key Suppliers Table 268. Synthetic Peptide Vaccine Distributors List Table 269. Synthetic Peptide Vaccine Customers List Table 270. Research Programs/Design for This Report Table 271. Authors List of This Report Table 272. Secondary Sources Table 273. Primary Sources List of Figures Figure 1. Synthetic Peptide Vaccine Image Figure 2. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Peptide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solution Phase Synthesis (SPS) Image Figure 5. Solid Phase Peptide Synthesis (SPPS) Image Figure 6. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Synthetic Peptide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Lung Cancer Image Figure 9. Prostate Cancer Image Figure 10. Breast Cancer Image Figure 11. Gastric Cancer Image Figure 12. Pancreatic Cancer Image Figure 13. Others Image Figure 14. Global Synthetic Peptide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Synthetic Peptide Vaccine Revenue (2021-2032) & (US$ Million) Figure 16. Global Synthetic Peptide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Synthetic Peptide Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2021-2032) Figure 19. Global Synthetic Peptide Vaccine Sales (2021-2032) & (K Units) Figure 20. Global Synthetic Peptide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Synthetic Peptide Vaccine Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Synthetic Peptide Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Europe Synthetic Peptide Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. China Synthetic Peptide Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Synthetic Peptide Vaccine Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Synthetic Peptide Vaccine Sales YoY (2021-2032) & (K Units) Figure 27. Global Synthetic Peptide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Synthetic Peptide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Synthetic Peptide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Synthetic Peptide Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021-2032) Figure 33. Global Synthetic Peptide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Synthetic Peptide Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Synthetic Peptide Vaccine Sales Market Share by Type (2021-2032) Figure 36. Global Synthetic Peptide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Synthetic Peptide Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021-2032) Figure 39. Global Synthetic Peptide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Synthetic Peptide Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Synthetic Peptide Vaccine Sales Market Share by Application (2021-2032) Figure 42. North America Synthetic Peptide Vaccine Revenue Share by Type (2021-2032) Figure 43. North America Synthetic Peptide Vaccine Sales Share by Type (2021-2032) Figure 44. North America Synthetic Peptide Vaccine Revenue Share by Application (2021-2032) Figure 45. North America Synthetic Peptide Vaccine Sales Share by Application (2021-2032) Figure 46. North America Synthetic Peptide Vaccine Revenue Share by Country (2021-2032) Figure 47. North America Synthetic Peptide Vaccine Sales Share by Country (2021-2032) Figure 48. Europe Synthetic Peptide Vaccine Revenue Share by Type (2021-2032) Figure 49. Europe Synthetic Peptide Vaccine Sales Share by Type (2021-2032) Figure 50. Europe Synthetic Peptide Vaccine Revenue Share by Application (2021-2032) Figure 51. Europe Synthetic Peptide Vaccine Sales Share by Application (2021-2032) Figure 52. Europe Synthetic Peptide Vaccine Revenue Share by Country (2021-2032) Figure 53. Europe Synthetic Peptide Vaccine Sales Share by Country (2021-2032) Figure 54. China Synthetic Peptide Vaccine Revenue Share by Type (2021-2032) Figure 55. China Synthetic Peptide Vaccine Sales Share by Type (2021-2032) Figure 56. China Synthetic Peptide Vaccine Revenue Share by Application (2021-2032) Figure 57. China Synthetic Peptide Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Synthetic Peptide Vaccine Revenue Share by Type (2021-2032) Figure 59. Asia Synthetic Peptide Vaccine Sales Share by Type (2021-2032) Figure 60. Asia Synthetic Peptide Vaccine Revenue Share by Application (2021-2032) Figure 61. Asia Synthetic Peptide Vaccine Sales Share by Application (2021-2032) Figure 62. Asia Synthetic Peptide Vaccine Revenue Share by Country (2021-2032) Figure 63. Asia Synthetic Peptide Vaccine Sales Share by Country (2021-2032) Figure 64. SAMEA Synthetic Peptide Vaccine Revenue Share by Type (2021-2032) Figure 65. SAMEA Synthetic Peptide Vaccine Sales Share by Type (2021-2032) Figure 66. SAMEA Synthetic Peptide Vaccine Revenue Share by Application (2021-2032) Figure 67. SAMEA Synthetic Peptide Vaccine Sales Share by Application (2021-2032) Figure 68. SAMEA Synthetic Peptide Vaccine Revenue Share by Country (2021-2032) Figure 69. SAMEA Synthetic Peptide Vaccine Sales Share by Country (2021-2032) Figure 70. Synthetic Peptide Vaccine Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Synthetic Peptide Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Solution Phase Synthesis (SPS)
  • Solid Phase Peptide Synthesis (SPPS)
Applications
  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastric Cancer
  • Pancreatic Cancer
  • Others
Companies covered
  • Merck
  • Targovax
  • TapImmune
  • Sumitomo Dainippon Pharma
  • Spotlight Innovation
  • Pharmasyntez
  • Peptech
  • OncoTherapy Science
  • Lytix Biopharma
  • ISA Pharmaceuticals
  • ImmunoCellular Therapeutics
  • Immatics biotechnologies
  • Celgene Corporation
  • Benovus Bio
  • Artificial Cell Technologies
  • Apitope Technology
  • Antigen Express
  • Anergis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Synthetic Peptide Vaccine Market by Type
  3. 1.2.1 Global Synthetic Peptide Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solution Phase Synthesis (SPS)
  5. 1.2.3 Solid Phase Peptide Synthesis (SPPS)
  6. 1.3 Synthetic Peptide Vaccine Market by Application
  7. 1.3.1 Global Synthetic Peptide Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Lung Cancer
  9. 1.3.3 Prostate Cancer
  10. 1.3.4 Breast Cancer
  11. 1.3.5 Gastric Cancer
  12. 1.3.6 Pancreatic Cancer
  13. 1.3.7 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Synthetic Peptide Vaccine Market Dynamics
  1. 2.1 Synthetic Peptide Vaccine Industry Trends
  2. 2.2 Synthetic Peptide Vaccine Industry Drivers
  3. 2.3 Synthetic Peptide Vaccine Industry Opportunities and Challenges
  4. 2.4 Synthetic Peptide Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Synthetic Peptide Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Synthetic Peptide Vaccine Revenue by Region
  3. 3.2.1 Global Synthetic Peptide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Synthetic Peptide Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Synthetic Peptide Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Synthetic Peptide Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Synthetic Peptide Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Synthetic Peptide Vaccine Sales by Region
  9. 3.4.1 Global Synthetic Peptide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Synthetic Peptide Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Synthetic Peptide Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Synthetic Peptide Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Synthetic Peptide Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Synthetic Peptide Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Synthetic Peptide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Synthetic Peptide Vaccine Sales by Manufacturers
  6. 4.2.1 Global Synthetic Peptide Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Synthetic Peptide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Synthetic Peptide Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Synthetic Peptide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Synthetic Peptide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Synthetic Peptide Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Synthetic Peptide Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Synthetic Peptide Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Synthetic Peptide Vaccine Tier 1, Tier 2, and Tier 3
5 Synthetic Peptide Vaccine Market by Type
  1. 5.1 Global Synthetic Peptide Vaccine Revenue by Type
  2. 5.1.1 Global Synthetic Peptide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Synthetic Peptide Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Synthetic Peptide Vaccine Sales by Type
  6. 5.2.1 Global Synthetic Peptide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Synthetic Peptide Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Synthetic Peptide Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Synthetic Peptide Vaccine Price by Type
6 Synthetic Peptide Vaccine Market by Application
  1. 6.1 Global Synthetic Peptide Vaccine Revenue by Application
  2. 6.1.1 Global Synthetic Peptide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Synthetic Peptide Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Synthetic Peptide Vaccine Sales by Application
  6. 6.2.1 Global Synthetic Peptide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Synthetic Peptide Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Synthetic Peptide Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Synthetic Peptide Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Synthetic Peptide Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Targovax
  8. 7.2.1 Targovax Company Information
  9. 7.2.2 Targovax Business Overview
  10. 7.2.3 Targovax Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Targovax Synthetic Peptide Vaccine Product Portfolio
  12. 7.2.5 Targovax Recent Developments
  13. 7.3 TapImmune
  14. 7.3.1 TapImmune Company Information
  15. 7.3.2 TapImmune Business Overview
  16. 7.3.3 TapImmune Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TapImmune Synthetic Peptide Vaccine Product Portfolio
  18. 7.3.5 TapImmune Recent Developments
  19. 7.4 Sumitomo Dainippon Pharma
  20. 7.4.1 Sumitomo Dainippon Pharma Company Information
  21. 7.4.2 Sumitomo Dainippon Pharma Business Overview
  22. 7.4.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio
  24. 7.4.5 Sumitomo Dainippon Pharma Recent Developments
  25. 7.5 Spotlight Innovation
  26. 7.5.1 Spotlight Innovation Company Information
  27. 7.5.2 Spotlight Innovation Business Overview
  28. 7.5.3 Spotlight Innovation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio
  30. 7.5.5 Spotlight Innovation Recent Developments
  31. 7.6 Pharmasyntez
  32. 7.6.1 Pharmasyntez Company Information
  33. 7.6.2 Pharmasyntez Business Overview
  34. 7.6.3 Pharmasyntez Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pharmasyntez Synthetic Peptide Vaccine Product Portfolio
  36. 7.6.5 Pharmasyntez Recent Developments
  37. 7.7 Peptech
  38. 7.7.1 Peptech Company Information
  39. 7.7.2 Peptech Business Overview
  40. 7.7.3 Peptech Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Peptech Synthetic Peptide Vaccine Product Portfolio
  42. 7.7.5 Peptech Recent Developments
  43. 7.8 OncoTherapy Science
  44. 7.8.1 OncoTherapy Science Company Information
  45. 7.8.2 OncoTherapy Science Business Overview
  46. 7.8.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio
  48. 7.8.5 OncoTherapy Science Recent Developments
  49. 7.9 Lytix Biopharma
  50. 7.9.1 Lytix Biopharma Company Information
  51. 7.9.2 Lytix Biopharma Business Overview
  52. 7.9.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio
  54. 7.9.5 Lytix Biopharma Recent Developments
  55. 7.10 ISA Pharmaceuticals
  56. 7.10.1 ISA Pharmaceuticals Company Information
  57. 7.10.2 ISA Pharmaceuticals Business Overview
  58. 7.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio
  60. 7.10.5 ISA Pharmaceuticals Recent Developments
  61. 7.11 ImmunoCellular Therapeutics
  62. 7.11.1 ImmunoCellular Therapeutics Company Information
  63. 7.11.2 ImmunoCellular Therapeutics Business Overview
  64. 7.11.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio
  66. 7.11.5 ImmunoCellular Therapeutics Recent Developments
  67. 7.12 Immatics biotechnologies
  68. 7.12.1 Immatics biotechnologies Company Information
  69. 7.12.2 Immatics biotechnologies Business Overview
  70. 7.12.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio
  72. 7.12.5 Immatics biotechnologies Recent Developments
  73. 7.13 Celgene Corporation
  74. 7.13.1 Celgene Corporation Company Information
  75. 7.13.2 Celgene Corporation Business Overview
  76. 7.13.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Celgene Corporation Synthetic Peptide Vaccine Product Portfolio
  78. 7.13.5 Celgene Corporation Recent Developments
  79. 7.14 Benovus Bio
  80. 7.14.1 Benovus Bio Company Information
  81. 7.14.2 Benovus Bio Business Overview
  82. 7.14.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Benovus Bio Synthetic Peptide Vaccine Product Portfolio
  84. 7.14.5 Benovus Bio Recent Developments
  85. 7.15 Artificial Cell Technologies
  86. 7.15.1 Artificial Cell Technologies Company Information
  87. 7.15.2 Artificial Cell Technologies Business Overview
  88. 7.15.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio
  90. 7.15.5 Artificial Cell Technologies Recent Developments
  91. 7.16 Apitope Technology
  92. 7.16.1 Apitope Technology Company Information
  93. 7.16.2 Apitope Technology Business Overview
  94. 7.16.3 Apitope Technology Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Apitope Technology Synthetic Peptide Vaccine Product Portfolio
  96. 7.16.5 Apitope Technology Recent Developments
  97. 7.17 Antigen Express
  98. 7.17.1 Antigen Express Company Information
  99. 7.17.2 Antigen Express Business Overview
  100. 7.17.3 Antigen Express Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Antigen Express Synthetic Peptide Vaccine Product Portfolio
  102. 7.17.5 Antigen Express Recent Developments
  103. 7.18 Anergis
  104. 7.18.1 Anergis Company Information
  105. 7.18.2 Anergis Business Overview
  106. 7.18.3 Anergis Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Anergis Synthetic Peptide Vaccine Product Portfolio
  108. 7.18.5 Anergis Recent Developments
8 North America
  1. 8.1 North America Synthetic Peptide Vaccine Market Size by Type
  2. 8.1.1 North America Synthetic Peptide Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Synthetic Peptide Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Synthetic Peptide Vaccine Price by Type (2021-2032)
  5. 8.2 North America Synthetic Peptide Vaccine Market Size by Application
  6. 8.2.1 North America Synthetic Peptide Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Synthetic Peptide Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Synthetic Peptide Vaccine Price by Application (2021-2032)
  9. 8.3 North America Synthetic Peptide Vaccine Market Size by Country
  10. 8.3.1 North America Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Synthetic Peptide Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Synthetic Peptide Vaccine Market Size by Type
  2. 9.1.1 Europe Synthetic Peptide Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Synthetic Peptide Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Synthetic Peptide Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Synthetic Peptide Vaccine Market Size by Application
  6. 9.2.1 Europe Synthetic Peptide Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Synthetic Peptide Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Synthetic Peptide Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Synthetic Peptide Vaccine Market Size by Country
  10. 9.3.1 Europe Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Synthetic Peptide Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Synthetic Peptide Vaccine Market Size by Type
  2. 10.1.1 China Synthetic Peptide Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Synthetic Peptide Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Synthetic Peptide Vaccine Price by Type (2021-2032)
  5. 10.2 China Synthetic Peptide Vaccine Market Size by Application
  6. 10.2.1 China Synthetic Peptide Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Synthetic Peptide Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Synthetic Peptide Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Synthetic Peptide Vaccine Market Size by Type
  2. 11.1.1 Asia Synthetic Peptide Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Synthetic Peptide Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Synthetic Peptide Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Synthetic Peptide Vaccine Market Size by Application
  6. 11.2.1 Asia Synthetic Peptide Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Synthetic Peptide Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Synthetic Peptide Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Synthetic Peptide Vaccine Market Size by Country
  10. 11.3.1 Asia Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Synthetic Peptide Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Synthetic Peptide Vaccine Market Size by Type
  2. 12.1.1 SAMEA Synthetic Peptide Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Synthetic Peptide Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Synthetic Peptide Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Synthetic Peptide Vaccine Market Size by Application
  6. 12.2.1 SAMEA Synthetic Peptide Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Synthetic Peptide Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Synthetic Peptide Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Synthetic Peptide Vaccine Market Size by Country
  10. 12.3.1 SAMEA Synthetic Peptide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Synthetic Peptide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Synthetic Peptide Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Synthetic Peptide Vaccine Value Chain Analysis
  2. 13.1.1 Synthetic Peptide Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Synthetic Peptide Vaccine Production Mode & Process
  6. 13.2 Synthetic Peptide Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Synthetic Peptide Vaccine Distributors
  9. 13.2.3 Synthetic Peptide Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst